BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 27191989)

  • 1. Proteomic analysis of stromal proteins in different stages of colorectal cancer establishes Tenascin-C as a stromal biomarker for colorectal cancer metastasis.
    Li M; Peng F; Li G; Fu Y; Huang Y; Chen Z; Chen Y
    Oncotarget; 2016 Jun; 7(24):37226-37237. PubMed ID: 27191989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissecting characteristics and dynamics of differentially expressed proteins during multistage carcinogenesis of human colorectal cancer.
    Peng F; Huang Y; Li MY; Li GQ; Huang HC; Guan R; Chen ZC; Liang SP; Chen YH
    World J Gastroenterol; 2016 May; 22(18):4515-28. PubMed ID: 27182161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tenascin C in colorectal cancer stroma is a predictive marker for liver metastasis and is a potent target of miR-198 as identified by microRNA analysis.
    Murakami T; Kikuchi H; Ishimatsu H; Iino I; Hirotsu A; Matsumoto T; Ozaki Y; Kawabata T; Hiramatsu Y; Ohta M; Kamiya K; Fukushima M; Baba S; Kitagawa K; Kitagawa M; Konno H
    Br J Cancer; 2017 Oct; 117(9):1360-1370. PubMed ID: 29065427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A quantitative proteomic approach of the different stages of colorectal cancer establishes OLFM4 as a new nonmetastatic tumor marker.
    Besson D; Pavageau AH; Valo I; Bourreau A; Bélanger A; Eymerit-Morin C; Moulière A; Chassevent A; Boisdron-Celle M; Morel A; Solassol J; Campone M; Gamelin E; Barré B; Coqueret O; Guette C
    Mol Cell Proteomics; 2011 Dec; 10(12):M111.009712. PubMed ID: 21986994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of stromal differentially expressed proteins in the colon carcinoma by quantitative proteomics.
    Mu Y; Chen Y; Zhang G; Zhan X; Li Y; Liu T; Li G; Li M; Xiao Z; Gong X; Chen Z
    Electrophoresis; 2013 Jun; 34(11):1679-92. PubMed ID: 23737015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-derived tenascin-C promotes the epithelial-mesenchymal transition in colorectal cancer cells.
    Takahashi Y; Sawada G; Kurashige J; Matsumura T; Uchi R; Ueo H; Ishibashi M; Takano Y; Akiyoshi S; Iwaya T; Eguchi H; Sudo T; Sugimachi K; Yamamoto H; Doki Y; Mori M; Mimori K
    Anticancer Res; 2013 May; 33(5):1927-34. PubMed ID: 23645740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomics analysis of differential protein expression identifies heat shock protein 47 as a predictive marker for lymph node metastasis in patients with colorectal cancer.
    Mori K; Toiyama Y; Otake K; Fujikawa H; Saigusa S; Hiro J; Kobayashi M; Ohi M; Tanaka K; Inoue Y; Kobayashi Y; Kobayashi I; Mohri Y; Goel A; Kusunoki M
    Int J Cancer; 2017 Mar; 140(6):1425-1435. PubMed ID: 27925182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of S100A8 and S100A9 as negative regulators for lymph node metastasis of gastric adenocarcinoma.
    Choi JH; Shin NR; Moon HJ; Kwon CH; Kim GH; Song GA; Jeon TY; Kim DH; Kim DH; Park DY
    Histol Histopathol; 2012 Nov; 27(11):1439-48. PubMed ID: 23018243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Over-expression of 14-3-3sigma in budding colorectal cancer cells modulates cell migration in the presence of tenascin-C.
    Ide M; Saito K; Tsutsumi S; Tsuboi K; Yamaguchi S; Asao T; Kuwano H; Nakajima T
    Oncol Rep; 2007 Dec; 18(6):1451-6. PubMed ID: 17982629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage mannose receptor 1 and S100A9 were identified as serum diagnostic biomarkers for colorectal cancer through a label-free quantitative proteomic analysis.
    Fan NJ; Chen HM; Song W; Zhang ZY; Zhang MD; Feng LY; Gao CF
    Cancer Biomark; 2016; 16(2):235-43. PubMed ID: 26682511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colorectal Cancer Cell Line Proteomes Are Representative of Primary Tumors and Predict Drug Sensitivity.
    Wang J; Mouradov D; Wang X; Jorissen RN; Chambers MC; Zimmerman LJ; Vasaikar S; Love CG; Li S; Lowes K; Leuchowius KJ; Jousset H; Weinstock J; Yau C; Mariadason J; Shi Z; Ban Y; Chen X; Coffey RJC; Slebos RJC; Burgess AW; Liebler DC; Zhang B; Sieber OM
    Gastroenterology; 2017 Oct; 153(4):1082-1095. PubMed ID: 28625833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Annexin II overexpression correlates with stromal tenascin-C overexpression: a prognostic marker in colorectal carcinoma.
    Emoto K; Yamada Y; Sawada H; Fujimoto H; Ueno M; Takayama T; Kamada K; Naito A; Hirao S; Nakajima Y
    Cancer; 2001 Sep; 92(6):1419-26. PubMed ID: 11745218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VEGF-A and Tenascin-C produced by S100A4+ stromal cells are important for metastatic colonization.
    O'Connell JT; Sugimoto H; Cooke VG; MacDonald BA; Mehta AI; LeBleu VS; Dewar R; Rocha RM; Brentani RR; Resnick MB; Neilson EG; Zeisberg M; Kalluri R
    Proc Natl Acad Sci U S A; 2011 Sep; 108(38):16002-7. PubMed ID: 21911392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TWIST1 and TWIST2 promoter methylation and protein expression in tumor stroma influence the epithelial-mesenchymal transition-like tumor budding phenotype in colorectal cancer.
    Galván JA; Helbling M; Koelzer VH; Tschan MP; Berger MD; Hädrich M; Schnüriger B; Karamitopoulou E; Dawson H; Inderbitzin D; Lugli A; Zlobec I
    Oncotarget; 2015 Jan; 6(2):874-85. PubMed ID: 25528769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of CXCR4 and SDF1 as prognostic factors for survival and the association with clinicopathology in colorectal cancer: A systematic meta-analysis.
    Li YP; Pang J; Gao S; Bai PY; Wang WD; Kong P; Cui Y
    Tumour Biol; 2017 Jun; 39(6):1010428317706206. PubMed ID: 28621237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive fluorogenic derivatization-liquid chromatography/tandem mass spectrometry proteomic analysis of colorectal cancer cell to identify biomarker candidate.
    Koshiyama A; Ichibangase T; Imai K
    Biomed Chromatogr; 2013 Apr; 27(4):440-50. PubMed ID: 22991145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphovascular invasion of colorectal cancer is correlated to SPARC expression in the tumor stromal microenvironment.
    Yoshimura T; Nagahara M; Kuo C; Turner RR; Soon-Shiong P; Hoon DS
    Epigenetics; 2011 Aug; 6(8):1001-11. PubMed ID: 21725199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
    Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
    Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of nemo-like kinase is an independent prognostic factor in colorectal cancer.
    Zhang W; He J; Du Y; Gao XH; Liu Y; Liu QZ; Chang WJ; Cao GW; Fu CG
    World J Gastroenterol; 2015 Aug; 21(29):8836-47. PubMed ID: 26269673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic analysis shows down-regulations of cytoplasmic carbonic anhydrases, CAI and CAII, are early events of colorectal carcinogenesis but are not correlated with lymph node metastasis.
    Wang N; Chen Y; Han Y; Zhao Y; Liu Y; Guo K; Jiang Y
    Tumori; 2012 Nov; 98(6):783-91. PubMed ID: 23389367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.